Metabolomics Identifies Biomarker Signatures to Differentiate Pancreatic Cancer from Type 2 Diabetes Mellitus in Early Diagnosis

<div>PCA scores of plasma metabolic profiles in PC, DM, and normal groups, suggesting good analytical stability and reliability of the UPLC-MS/MS workflow, as well as the plasma metabolite profile. <i>t</i>[<a href="/journals/ije/2021/9990768/#B1">1</a>]: the first principal component; t[<a href="/journals/ije/2021/9990768/#B2">2</a>]: the second principal component.</div>

International Journal of Endocrinology

fig2

Figure 2

Figure 2: Metabolomics Identifies Biomarker Signatures to Differentiate Pancreatic Cancer from Type 2 Diabetes Mellitus in Early Diagnosis 